Multiple testing to establish superiority/equivalence of a new treatment compared with kappa standard treatments

被引:0
|
作者
Dunnett, CW
Tamhane, AC
机构
[1] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON, ON L8S 4K1, CANADA
[2] NORTHWESTERN UNIV, DEPT STAT, EVANSTON, IL 60208 USA
[3] NORTHWESTERN UNIV, DEPT IND ENGN & MANAGEMENT SCI, EVANSTON, IL 60208 USA
关键词
D O I
10.1002/(SICI)1097-0258(19971115)16:21<2489::AID-SIM684>3.0.CO;2-D
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this paper we develop multiple hypotheses testing procedures to compare a new treatment with a set of standard treatments in a clinical trial. The aim is to classify the new treatment with respect to each of the standards, by specifying those to which the new treatment is superior, those to which the new treatment is equivalent and those to which one can establish neither superiority nor equivalence. We propose several stepwise procedures and compare them with respect to their family wise error rates and power. The step-down methods SD1 and SD2 test for superiority first, followed by tests for equivalence for those comparisons where we cannot establish superiority. The step-up methods SU1 and SU2 test for equivalence first, followed by tests for superiority for those comparisons where we can establish at least equivalence. The methods SD3 and SU3 apply the tests for superiority and equivalence in pairs. All the methods require that we specify a threshold value delta > 0 in advance for defining equivalence. In applications where it is not possible to specify a value delta, we can use the method SD1 by testing for superiority first, followed by one-sided confidence limits on the efficacy differences for those comparisons where we cannot establish superiority. (C) 1997 by John Wiley & Sons, Ltd.
引用
收藏
页码:2489 / 2506
页数:18
相关论文
共 50 条
  • [21] Superiority of the new Agent LCZ696 for the Treatment of systolic Heart Failure compared to Analapril PARADIGM-HF Study
    Ozcelik, C.
    [J]. KARDIOLOGE, 2014, 8 (06): : 443 - 444
  • [23] Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial
    Zertal, Amel
    Marrouni, Kanza Alami
    Arbour, Nathalie
    Jutras-Aswad, Didier
    Pomey, Marie-Pascale
    Rouleau, Isabelle
    Prat, Alexandre
    Larochelle, Catherine
    Beaulieu, Pierre
    Chamelian, Laury
    Sylvestre, Marie-Pierre
    Morin, Danielle
    Ouellette, Jean-Sylvain
    Frejeau, Nathalie
    Duquette, Pierre
    [J]. FRONTIERS IN NEUROLOGY, 2024, 15
  • [24] Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared to current standard practice in Sweden
    Kobelt, G.
    Berg, J.
    Lindgren, P.
    Hillert, J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A239 - A240
  • [25] A STUDY TO ASSESS THE EFFECTS OF A NEW BETADINE CREAM FORMULATION COMPARED TO A STANDARD TOPICAL TREATMENT REGIMEN FOR BURNS
    DEKOCK, M
    VANDERMERWE, AE
    [J]. BURNS, 1987, 13 (01) : 69 - 74
  • [26] A REVIEW: LAPAROSCOPY AS THE NEW STANDARD FOR TREATMENT OF EARLY STAGE ENDOMETRIAL CANCER AS COMPARED TO THE MORE TRADITIONAL APPROACH?
    Bhagat, N.
    Kalkur, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 967 - 969
  • [27] Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China
    Huang, Yun
    Zhou, Hua
    Fang, Chongbo
    Ma, Lili
    Zhang, Yuyu
    Rong, Weibo
    Liu, Xiaoli
    Ye, Honghua
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (01) : 86 - 92
  • [28] Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden
    Kobelt, G.
    Berg, J.
    Lindgren, P.
    Jonsson, B.
    Stawiarz, L.
    Hillert, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (05) : 679 - 690
  • [29] Superiority of a new gradient system utilizing a critical threshold for the adsorption capacity of polypeptides to column packing when compared with a standard gradient system for the simultaneous and quantitative analysis of polypeptides
    Goda, Ryoya
    Masumoto, Hiroshi
    Okazaki, Osamu
    Sudo, Kenichi
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (08) : 857 - 866
  • [30] Superior outcome after early autotransplantation (AT) with ''total therapy'' (TT) compared to standard SWOG treatment (ST) for multiple myeloma (MM).
    Barlogie, B
    Crowley, J
    Jagannath, S
    Vesole, D
    Tricot, G
    Jacobson, J
    Salmon, S
    [J]. BLOOD, 1995, 86 (10) : 816 - 816